The Research and Development team at HOOKIPA Pharma Inc. focuses on pioneering the development of advanced immunotherapies using their proprietary arenavirus platform. This team integrates expertise in virology, bioinformatics, immunology, and clinical biomarkers to design, test, and refine treatments targeting various cancers, including HPV16+ and KRAS-mutated cancers, and infectious diseases such as HBV and HIV. With roles ranging from vice presidents to junior scientists, they work collaboratively to push the boundaries of innovation, aiming to create functional cures and improve the quality of life for patients.
View all